A 65-year-old man presents to your office with right flank pain and increased urinary frequency. He denies fevers or chills. He is otherwise healthy and has no pertinent medical or surgical history.
A 26-year-old man presented to the emergency department with traumatic fractures of the left radius and ulna. He had no significant medical history, was a nonsmoker, and was not taking medication at the time of presentation.
Patients with known Fabry disease are at an increased risk for cardiovascular dysfunction. Do you know which cardiovascular manifestation is the most common?
He talks about HIV resistance in the context of pre-exposure prophylaxis use, how common it is, and how PrEP might influence subsequent therapies.
One afternoon, a 28-year-old man presented to the emergency department. He told the triage nurse that he had stomach pain and nausea and repeated the same complaints to Dr V when she came in to examine him.
In this podcast, Jaspal Singh, MD, MHA, MHS, interviews Ryan Maves, MD, on managing resources to manage patients with COVID-19 when faced with shortages of medications, equipment, staffing, and hospital beds.
A 13-year-old boy presented to our pediatric emergency department with acute onset of right testicular pain, which had started approximately 4 hours prior to arrival.
In this commentary, Raymond Chung, MD, from Massachusetts General Hospital, explains why it is key to stage a patient’s disease after an HCV diagnosis—and how to do it.
An unresponsive 47-year-old woman with uncontrolled type 2 diabetes was brought to the emergency department because of a hypoglycemic episode. After her mental status had improved following administration of intravenous dextrose, it was discovered that she had a progressive history of unintentional weight loss, flank pain, edema, and dyspnea upon exertion over the past several months.
In this soundbite, William Schaffner, MD, speaks about whether concomitant receipt of recombinant zoster vaccine with another vaccine increases the risk of herpes zoster compared with receiving recombinant zoster vaccine alone. This topic was presented at the 2021 virtual Annual Conference on Vaccinology Research sponsored by the National Foundation for Infectious Diseases.